Get the Stockscreener App
0.5666
11.09%
0.05
Harvard Bioscience Inc stock is traded at $0.5666, with a volume of 7.22M.
It is up +11.09% in the last 24 hours and up +27.82% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.5166
Open:
$0.5345
24h Volume:
7.22M
Relative Volume:
1.27
Market Cap:
$25.54M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.833
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+42.76%
1M Performance:
+27.82%
6M Performance:
+65.06%
1Y Performance:
-76.09%
1-Day Range:
$0.52
$0.645
1-Week Range:
$0.3965
$0.94
52-Week Range:
$0.2813
$2.82
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.5735 | 23.00M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
541.98 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
176.81 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.52 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.36 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.05 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Will Harvard Bioscience Inc. stock gain from strong economyJuly 2025 Reactions & Consistent Return Strategy Ideas - newser.com
How Harvard Bioscience Inc. stock trades before earnings2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Analyzing Harvard Bioscience Inc. with risk reward ratio chartsQuarterly Performance Summary & Technical Entry and Exit Tips - newser.com
Will Harvard Bioscience Inc. stock benefit from sector rotationWeekly Profit Report & Fast Gain Stock Tips - newser.com
Why Harvard Bioscience Inc. stock is seen as undervaluedMarket Activity Report & Reliable Entry Point Trade Alerts - newser.com
Book value per share of Harvard Bioscience, Inc. – MUN:HBI - TradingView
What moving averages say about Harvard Bioscience Inc.2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
Will Harvard Bioscience Inc. stock outperform Nasdaq index2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Using fundamentals and technicals on Harvard Bioscience Inc.2025 Buyback Activity & Entry Point Confirmation Alerts - newser.com
Key resistance and support levels for Harvard Bioscience Inc.Quarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
Harvard Bioscience, Inc. (HBIO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Published on: 2025-10-31 10:27:00 - newser.com
Harvard Bioscience, Inc. (HBIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance Singapore
Harvard Bioscience, Inc. (HBIO) Stock forecasts - Yahoo! Finance UK
Is Harvard Bioscience Inc. stock a buy before product launchesRate Cut & Safe Capital Growth Stock Tips - newser.com
Can Harvard Bioscience Inc. stock hit analyst price targetsJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Published on: 2025-10-31 05:08:20 - newser.com
Is Harvard Bioscience Inc. stock a contrarian buyMarket Activity Recap & Free Community Consensus Stock Picks - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergers2025 Macro Impact & Consistent Income Trade Ideas - newser.com
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround? - ts2.tech
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 ... - Bluefield Daily Telegraph
Harvard Bioscience (Nasdaq: HBIO) schedules earnings call to discuss Q3 2025 results - Stock Titan
Published on: 2025-10-30 04:49:01 - newser.com
Applying Wyckoff theory to Harvard Bioscience Inc. stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Why Harvard Bioscience Inc. (HBI) stock could break out in 2025Weekly Trade Summary & Reliable Momentum Entry Alerts - fcp.pa.gov.br
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):